{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:44:44Z","timestamp":1780073084015,"version":"3.54.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Glutaric aciduria type II (GA II) is an autosomal recessive metabolic disorder of fatty acid, amino acid, and choline metabolism. The late-onset form of this disorder is caused by a defect in the mitochondrial electron transfer flavoprotein dehydrogenase or the electron transfer flavoprotein dehydrogenase (<jats:italic>ETFDH<\/jats:italic>) gene. Thus far, the high clinical heterogeneity of late-onset GA II has brought a great challenge for its diagnosis. In this study, we reported a 21-year-old Chinese man with muscle weakness, vomiting, and severe pain. Muscle biopsy revealed myopathological patterns of lipid storage myopathy, and urine organic acid analyses showed a slight increase in glycolic acid. All the aforementioned results were consistent with GA II. Whole-exome sequencing (WES), followed by bioinformatics and structural analyses, revealed two compound heterozygous missense mutations: c.1034A &amp;gt; G (p.H345R) on exon 9 and c.1448C&amp;gt;A (p.P483Q) on exon 11, which were classified as \u201clikely pathogenic\u201d according to American College of Medical Genetics and Genomics (ACMG). In conclusion, this study described the phenotype and genotype of a patient with late-onset GA II. The two novel mutations in <jats:italic>ETFDH<\/jats:italic> were found in this case, which further expands the list of mutations found in patients with GA II. Because of the treatability of this disease, GA II should be considered in all patients with muscular symptoms and acute metabolism decompensation such as hypoglycemia and acidosis.<\/jats:p>","DOI":"10.3389\/fneur.2023.1087421","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T05:41:06Z","timestamp":1674798066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Novel ETFDH compound heterozygous mutations identified in a patient with late-onset glutaric aciduria type II"],"prefix":"10.3389","volume":"14","author":[{"given":"Sijia","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S1096-7192(02)00138-5","article-title":"Glutaric acidemia type II: gene structure and mutations of the electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene","volume":"77","author":"Goodman","year":"2002","journal-title":"Mol Genet Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF02312527","article-title":"Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II","volume":"3","author":"Gregersen","year":"1980","journal-title":"J Inherit Metab Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00239-009-9263-0","article-title":"Acyl-CoA dehydrogenases: dynamic history of protein family evolution","volume":"69","author":"Swigonov\u00e1","year":"2009","journal-title":"J Mol Evol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/jhg.2014.10","article-title":"Riboflavin-responsive multiple Acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients","volume":"59","author":"Zhu","year":"2014","journal-title":"J Hum Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/hmg\/ddab308","article-title":"Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study","volume":"31","author":"Wen","year":"2022","journal-title":"Hum Mol Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF03047371","article-title":"Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency)","volume":"7","author":"Goodman","year":"1984","journal-title":"J Inherit Metab Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/humu.10226","article-title":"Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency","volume":"22","author":"Olsen","year":"2003","journal-title":"Hum Mutat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-014-0117-5","article-title":"Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency","volume":"9","author":"Gr\u00fcnert","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.braindev.2015.08.011","article-title":"Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type II: characteristics in comparison with pediatric cases","volume":"38","author":"Yamada","year":"2016","journal-title":"Brain Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00415-020-09729-z","article-title":"Multiple acyl-COA dehydrogenase deficiency in elderly carriers","volume":"267","author":"Macchione","year":"2020","journal-title":"J Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1074\/jbc.M805719200","article-title":"Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation","volume":"284","author":"Henriques","year":"2009","journal-title":"J Biol Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1212\/01.wnl.0000240065.35635.a6","article-title":"Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missed diagnosis?","volume":"67","author":"K\u00f6ppel","year":"2006","journal-title":"Neurology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.msard.2020.102689","article-title":"Late-onset MADD in Yemen caused by a novel ETFDH mutation misdiagnosed as ADEM","volume":"48","author":"Lian","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/hmg\/dds175","article-title":"Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency","volume":"21","author":"Cornelius","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpn.2011.07.003","article-title":"Developmental evolution in a patient with multiple acyl-coenzymeA dehydrogenase deficiency under pharmacological treatment","volume":"16","author":"Rosa","year":"2012","journal-title":"Eur J Paediatr Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain."},{"key":"B17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/jnnp.2009.176404","article-title":"Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations","volume":"81","author":"Wen","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-018-0903-5","article-title":"Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency","volume":"17","author":"Missaglia","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10545-013-9671-6","article-title":"Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency","volume":"37","author":"Xi","year":"2014","journal-title":"J Inherit Metab Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00109-011-0725-7","article-title":"Wu Z-Y. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c250G","volume":"89","author":"Wang","year":"2011","journal-title":"A J Mol Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/10409238.2021.1908952","article-title":"dehydrogenase advances in molecular genetics and impact on treatment","volume":"56","author":"Missaglia","year":"2021","journal-title":"Crit Rev Biochem Mol Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ymgme.2022.09.004","article-title":"Clinical and biochemical footprints of inherited metabolic disorders: X. Metabolic myopathies","volume":"137","author":"Angelini","year":"2022","journal-title":"Mol Genet Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods."},{"key":"B25","doi-asserted-by":"publisher","first-page":"D427","DOI":"10.1093\/nar\/gky995","article-title":"The Pfam protein families database in 2019","volume":"47","author":"El-Gebali","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0076-6879(04)83004-0","article-title":"Protein structure prediction using Rosetta","volume":"383","author":"Rohl","year":"2004","journal-title":"Methods Enzymol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6807-11-43","article-title":"Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motif","volume":"11","author":"Er","year":"2011","journal-title":"BMC Struct Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/oxfordjournals.jbchem.a021410","article-title":"In vitro refolding and unfolding of subunits of electron-transferring flavoprotein: characterization of the folding intermediates and the effects of FAD and AMP on the folding reaction","volume":"120","author":"Sato","year":"1996","journal-title":"J Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.genom.7.080505.115737","article-title":"Protein misfolding and human disease","volume":"7","author":"Gregersen","year":"2006","journal-title":"Annu Rev Genomics Hum Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.2174\/092986710793205462","article-title":"Emerging roles for riboflavin in functional rescue of mitochondrial \u03b2-oxidation flavoenzymes","volume":"17","author":"Henriques","year":"2010","journal-title":"Curr Med Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"704984","DOI":"10.3389\/fnut.2021.704984","article-title":"Glutaric acidemia, pathogenesis and nutritional therapy","volume":"8","author":"Li","year":"2021","journal-title":"Front Nutr."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1087421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T05:41:10Z","timestamp":1674798070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1087421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":31,"alternative-id":["10.3389\/fneur.2023.1087421"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1087421","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"article-number":"1087421"}}